In the past ten years there has been considerable interest in the study of esophageal function in patients with diabetes mellitus. This has primarily resulted (1) from the knowledge that esophageal motility is likely to be affected by diabetic neuropathy, and (2) from the accessibility of the esophagus. However, it should be noted that clinical evidence of esophageal dysfunction is not an important complication of diabetes. In this chapter four questions will be addressed. (1) What is the prevalence of esophageal motor dysfunction in diabetes? (2) What are its clinical features? (3) What is the pathogenesis of this motor disorder? and, (4) Are other esophageal diseases also found in diabetes?
What is the prevalence of esophageal motor dysfunction in diabetics? Mandelstam and Lieber were the first to survey a group of diabetics for evidence of esophageal involvement [1] . They reported that the emptying of barium from the esophagus was delayed in nearly all diabetics with peripheral neuropathy. Later, they found that this group also exhibited a decrease in the frequency of peristaltic contractions after swallowing. Ten years later, in a larger study, Hollis et al. found that 80 percent of diabetics with peripheral neuropathy had abnormal esophageal motility [2] . In contrast, only 20 percent of diabetics without neuropathy had abnormal esophageal motility.
In general, the esophageal changes in diabetes can be described as a loss of motility. (1) ing, and the esophageal transit time for barium [2] and for water labeled with a radioisotope [3] is increased in diabetes. These changes, though, are not specific for diabetes, but can also be seen in reflux esophagitis, scleroderma, alcoholic neuropathy, intestinal pseudobstruction, and other diseases.
It seems that the more severe the neuropathy, the greater the likelihood of esophageal involvement. Virtually all patients with autonomic dysfunction, whether gastrointestinal, vascular, or genitourinary, have abnormalities of esophageal motility. However, in patients with peripheral neuropathy without symptoms of autonomic involvement, only 50 percent have esophageal abnormalities [3] .
What are the clinical features of esophageal motor dysfunction in diabetes?
The esophageal motility changes of loss of peristalsis and delayed transit would be likely to produce dysphagia or esophagitis. The latter is theorized, since impaired clearance of acid is an important feature of reflux esophagitis. However, most studies agree that esophageal symptoms are quite uncommon in diabetics. In the study by Hollis et al., while 56 percent of the diabetics had abnormal motility, only one of 50 had frequent heartburn. In that study, as well as in several other large surveys, few patients complained of dysphagia. In fact, dysphagia is so uncommon in diabetics that when present an exhaustive search should be made to exclude the usual causes of dysphagia rather than ascribing that symptom to diabetes.
What is the pathogenesis of these motility abnormalities?
The esophagus, like the rest of the gastrointestinal tract, responds to vagal stimulation. The principal effects of the vagus are relaxation of the lower esophageal sphincter and peristalsis throughout the esophagus from the proximal striated muscle portion to the distal smooth muscle portion. However, vagotomy does not produce any characteristic alterations of esophageal motility. Both peristalsis and sphincter relaxation remain intact in the externally denervated esophagus. The myenteric plexuses within the esophageal wall act as the "brain of the esophagus" and, in response to local afferent stimuli, coordinate peristalsis and relaxation. By way of comparison, the myenteric plexuses have a similar function in the rest of the gastrointestinal tract, but vagotomy results in distinctive alterations in gastric relaxation and small bowel digestive myo-electric activity.
In diabetes the neuropathologic alterations in the esophagus, as described by Smith , are (1) Schwann cell loss in the parasympathetic fibers, both in the wall and in extrinsic nerves; (2) demyelination and Wallerian change in the vagus; and (3) preservation of the myenteric plexus [4] . These findings are consistent with the manometric features of diabetes. Parasympathetic cholinergic stimulation in man seems to be primarily involved with peristalsis. Thus, the observation of a slowing of peristalsis would be compatible with a loss of cholinergic stimulation. Hollis et al.
have shown that the muscle itself responds to cholinergic stimulation appropriately. Since the myenteric plexus, which has a major role in the regulation of esophageal motility, is normal in diabetes, esophageal function is sufficiently preserved to prevent dysphagia.
Are other esophageal diseases also found in diabetes? CANDIDIASIS Diabetes is felt to be a predisposing condition for candida esophagitis. Most texts list the association without reference. In fact, it may be that, due to the known predilection for diabetics to develop vaginal or oral thrush, esophageal disease has been inferred. In one series of prospective patients in which smears were taken from the esophagus at endoscopy, three of 27 patients with candida were diabetics [5] .
The diagnosis of candida esophagitis is established by the appearance of raised white plaques on the mucosa, which on smear contained buds or hyphae. Cultures from the esophagus are not worthwhile, as two-thirds of control patients can have positive cultures. The measurement of agglutinin titers to candida in sera is helpful, as a titer of 1/160 or greater is found in 100 percent of candidiasis cases and up to 17 percent of controls.
There are two treatment modalities; one is nystatin (Mycostatin), 800,000 units, three to four times a day. It can be given as mouthwash, gargle and swallow, or suspended in 1 percent methyl cellulose to enhance its adherence to the wall [6] . The other option is the use of Ketoconazole, 200 mg daily. This agent is well-tolerated, and compliance may be better than with nystatin.
DIFFUSE INTRAMURAL ESOPHAGEAL PSEUDODIVERTICULOSIS This is an uncommon esophageal condition in which multiple out-pouchings from the esophageal wall are found (Fig. 1) . It may be localized or diffuse. The diffuse condition is more relevant clinically, presenting with dysphagia due to an associated stricture in most cases [7] . The stricture is unique in that most are found in the upper third of the esophagus. At times the mucosal ulcerations in a severe candida esophagitis can be confused with this entity. It is thought that a co-existent inflammatory process obstructs the mucus glands in the esophageal wall leading to dilatation and the appearance of diverticula. The course is benign, with treatment directed to the underlying esophagitis and stricture. As of 1977, of the 29 reported cases, five were diabetics. This is probably a chance association. SUMMARY Neuropathic complications in diabetes frequently result in a mild loss of esophageal contraction amplitude, a slowing of the velocity of peristalsis, and a resultant delay in esophageal emptying. But more severe abnormalities are uncommon, and that degree of esophageal motor change does not cause symptoms. When dysphagia or chest pain occur in diabetics, they should be thoroughly investigated with X-ray, endoscopy, and, if warranted, motility. The only condition which probably occurs with greater frequency in diabetes is esophageal candidiasis.
